Current dogma asserts that mammalian lifelong blood production is established by a small number of blood progenitors. However, this model is based on assays that require the disruption, transplantation and/or culture of embryonic tissues. Here, we used the sample-to-sample variance of a multicoloured lineage trace reporter to assess the frequency of emerging lifelong blood progenitors while avoiding the disruption, culture or transplantation of embryos. We find that approximately 719 Flk1 + mesodermal precursors, 633 VE-cadherin + endothelial precursors and 545 Vav1 + nascent blood stem and progenitor cells emerge to establish the haematopoietic system at embryonic days (E)7-E8.5, E8.5-E11.5 and E11.5-E14.5, respectively. We also determined that the spatio-temporal recruitment of endothelial blood precursors begins at E8.5 and ends by E10.5, and that many c-Kit + clusters of newly specified blood progenitors in the aorta are polyclonal in origin. Our work illuminates the dynamics of the developing mammalian blood system during homeostasis.
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. From here, they circulate to the fetal liver (FL), expand, and then seed the bone marrow (BM) 1 . Transplantation studies estimate <1 HSC per embryo at E10.5 and between 1-2 HSCs per embryo at E11. 5 (refs 2-11) . However, live imaging and multicolour fate mapping of zebrafish HE reveals much greater numbers of phenotypic HSCs and about 30 functional longterm HSC clones emerging from the mid-gestation dorsal aorta [12] [13] [14] . Recently, the reaggregation of mouse aorta-gonads-mesonephros (AGM) with BM-derived OP9 stromal cells and limiting dilution transplantation estimated 50 and 70 murine HSC precursors at E10.5 and E11.5, respectively 15 . It is impossible to know, however, whether predictions made on the basis of non-physiological ex vivo niches faithfully reflect in vivo HSC formation. Furthermore, recent work reveals that transplantation probably fails to read out the full repertoire of cells sustaining lifelong haematopoiesis during homeostasis [16] [17] [18] . Thus, any transplantation-based approach almost certainly underestimates HSC and precursor numbers. Here, we sought to measure the number of independently specified precursors contributing to lifelong haematopoiesis at distinct stages of mouse ontogeny using an approach unbiased by transplantation or ex vivo manipulation. We took advantage of the ROSA26 +/Confetti allele (Confetti allele) 19 , which is recombined by Cre recombinase (CRE) to label cellular progeny randomly with GFP, YFP, RFP or CFP (that is, Confetti-labelled cells) (Fig. 1a) . Here, we establish that the sample-to-sample variance (SSV) in the distribution of Confetti colours in murine peripheral blood (PB) correlates with the number of cells initially labelled with CRE, either during embryogenesis or in adults. We exploit this observation to discover that hundreds of precursors emerge throughout mouse ontogeny to establish lifelong haematopoiesis.
RESULTS

SSV in the distribution of Confetti colours predicts initiating cells in vitro
Classic studies successfully employed SSV, using the binomial or Poisson models, to estimate HSC numbers in adult mice [20] [21] [22] [23] [24] . Here, we took a similar approach to analyse the embryo using the Confetti allele 19 ( Fig. 1a) . This system has been used to visualize the clonal dynamics of solid tissue stem cells, but has not yet been applied to studies of haematopoiesis 19, 25 . We hypothesized that the SSV in the distribution of Confetti colours in the PB would correlate with the number of Confetti-labelled precursors contributing to lifelong haematopoiesis such that large numbers of Confetti + precursors would yield a low variance and a small number of Confetti (upper bound). This linear regression had an R 2 of 0.75 and an adjusted R 2 of 0.73, and P < 0.00001 (F(1,13) == 39.21). For the 15 residuals within the range tested, the skew was 0.06 and the kurtosis 2.34, whereas a perfectly normal distribution would have a skew of 0 and a kurtosis of 3.
A R T I C L E S
In d-f the results represent three independent similar experiments (n = 24 wells). (g) Labelling efficiency of iCCs treated with different concentrations of 4-OHT. The error bars indicate ±s.d. of mean (n = 9 in all groups, but n = 5 for 600 nM). Individual data points are shown in red. This experiment was repeated twice. (h) Confetti-based estimates were normalized to labelling efficiency as follows: total initiating events = estimate × (100/percentage of Confetti + cells). The resulting reporter labelling efficiencies were grouped into four categories (3%, 17%, 40-45% and 67-78%). The average Confettibased estimate of numbers of initially plated cells after normalization is shown (error bars indicate ±s.d. of mean). Confetti-based estimates of numbers of initiating events maintain fidelity when the labelling efficiency is >3% and >500 cells are examined. Estimates were obtained from n = 18 plated replicates for all of the different 4-OHT concentrations with the exception of 600 nm (n = 9). Results represent two independent similar experiments. Source data are provided in Supplementary Table 1. hypothesis empirically by generating an immortalized fibroblast cell line from ROSA26 ERT2-Cre/Confetti mice ('inducible Confetti cells' or iCCs) (Fig. 1c) . Treatment of iCCs with (Z)-4-hydroxytamoxifen (4-OHT) resulted in a distribution of Confetti colours that was stable and specific to this cell line ( Fig. 1d and Supplementary Fig. 1 ). Here, the GFP + allele was under-favoured, as has been previously reported 19 . We plated replicates of 5-50,000 4-OHT-treated iCCs, expanded these cells in culture, and then analysed the distribution of Confetti colours by flow cytometry (Fig. 1c) . The coefficient of variance (CV, standard deviation/mean) amongst colours and between wells was calculated for each individual Confetti colour at each plated cell number. As expected, a decrease in the initial plated cell number correlated with an increase in the observed CV for each individual Confetti colour (Fig. 1e) . From here onwards, CV will refer to the SSV in the distribution of the Confetti colours. Next, we examined the average log 10 (CV) for YFP, CFP and RFP versus the log 10 (cell number) and observed a linear relationship between 50 and 2,500 starting cells that yielded the following formula for estimating starting cell numbers based on SSV: cell number = 10 (−1.56(log 10 CV)+1.47) (Fig. 1f , see Methods and legend for additional details on formula derivation). This formula yielded accurate starting cell number estimates at Confetti labelling efficiencies of >3% and when >500 cells were analysed (Fig. 1g,h (Fig. 2a,b) . Because blood derives from endothelium, VE-cadherin Cre labels the entire haematopoietic compartment 26 . Historically, the frequency of transplantable WBM HSCs is consistently estimated as about 1/10,000 (refs 27-33) . Thus, we expected recipients to engraft with about 500, 100 and 20 long-term HSCs (LT-HSCs), respectively. By 32 weeks post-transplant, in three independent experiments, the observed log 10 (CV) of the Confetti colours in CD45.2 + PB estimated reconstitution with an average of 592 ± 260, 220 ± 19, and 121 ± 16 LT-HSCs in recipients of 5 × 10 6 , 1 × 10 6 or 2 × 10 5 WBM cells, respectively ( Fig. 2b and Supplementary Table 1 ). As 20 initiating events falls outside our window of precision (Fig. 1f) , it is not surprising that our formula did not accurately estimate this value. The log 10 (CV) of Confetti colours in CD45.2 + PB at earlier time points post-transplant (4-16 weeks) revealed large numbers of initiating events (that is, repopulating units, RUs) in all transplanted mice (Fig. 2b) . This number steadily declined over time in recipients. This pattern reflects the well-established gradual exhaustion of short-term HSCs and progenitors over time post-transplant [34] [35] [36] . In a second experiment, Confetti + WBM was transplanted at limiting dilution (Fig. 2a,c and Supplementary Fig. 2a,b) . Here, the precise input of RUs could be independently confirmed by limiting dilution analysis (LDA). Our Confetti-based RU estimate correlated precisely with that predicted via LDA at 20 weeks post-transplant ( Fig. 2c and Supplementary Fig. 2a ,b and Supplementary Table 1 ). These experiments confirm that SSV in the distribution of Confetti colours accurately reflects changes in initiating cell numbers in a reconstituting haematopoietic system. Transplantable HSCs in the E11.5 AGM expand dramatically during ex vivo explant culture 37 . Thus, we tested whether our Confetti approach could detect this increase. One to five embryo equivalents of E11.5 AGM-derived cells were isolated from CD45.2
+
ROSA26
+/Confetti VE-cadherin +/Cre embryos and transplanted into lethally irradiated CD45.1 + CD45.2 + mice (Fig. 2d ). There was significant CD45.2 + engraftment in 6/15 recipients (Fig. 2e) . In two of these recipients, the CD45.2 + PB was primarily labelled with a single Confetti colour (Fig. 2f) Fig. 2c ). This confirms previous reports that few newly specified HSCs are detected when transplanted into adult recipients [2] [3] [4] . E11.5 CD45.2 + ROSA26 +/Confetti VE-cadherin
AGMs were next cultured as explants for three days, dissociated and then transplanted at one embryo equivalent into lethally irradiated CD45.1 + CD45.2 + recipients (Fig. 2d) . Here, 7/7 recipients displayed >90% CD45.2 + PB, of which 25-65% was Confetti + (Fig. 2e,f) . The resulting average log 10 Supplementary Fig. 2d ). These data confirm a >150-fold expansion of HSCs during ex vivo AGM-explant culture, as reported previously 37 . The de novo appearance of Confetti + cells in the PB of AGM-explant recipients (Fig. 2f) indicates that some of this expansion is due to ongoing nascent specification, as previously reported 37 . This experiment further confirms that SSV in the distribution of Confetti colours faithfully reflects changes in initiating cell numbers in vivo.
We next tested our formula for estimating numbers of initiating cells in a non-transplant-based biological context. Haematopoiesis in adult mice is sustained by thousands of haematopoietic progenitors 16, 18 . Thus, we utilized tamoxifen (TAM)-treated adult ROSA26 ERT2-Cre/Confetti mice as a control for large numbers of PB contributing events, expecting low SSV of Confetti colours to reflect large numbers of newly labelled independent clones (Fig. 3a,b 16, 18 . To approximate small numbers of initiating events, we employed the E2a driver, which is first expressed by blastomeres during early murine development (Fig. 3a ) 38 Fig. 3c and Supplementary Fig. 3a and Supplementary Table 1 ). Further, the distribution of Confetti colours in the blood and other mesodermal, ectodermal and endodermal tissues was similar and stochastic in individual ROSA26 +/Confetti E2a +/Cre mice, confirming E2a-Cre activation early in development in very few cells ( Supplementary Fig. 4b-d) . Thus, the estimated numbers of initiating events for both ROSA26 ERT2-Cre/Confetti and ROSA26
+/Confetti
E2a
+/Cre mice demonstrate that our formula performs as expected in a biological context. cell dose (n = 2 experiments). For each experiment and cell dose, five mice were transplanted, with the exception of experiment 2 (four mice) and experiment 1 (four recipients for 2 × 10 5 cell dose) (Supplementary Table 1 Hundreds of embryonic precursors contribute to lifelong haematopoiesis We next sought to measure the number of independently specified precursors contributing to lifelong haematopoiesis at distinct stages of mouse development. HSCs derive from haemogenic endothelium that is mesodermal in origin 1 . Thus, we interrogated the clonal complexity of haematopoietic precursors as they emerge from mesoderm and endothelium by analysing the SSV of PB Confetti colours in cohorts of 
ROSA26
+/Confetti Flk1 +/Cre (n = 7) and ROSA26 +/Confetti VE-cadherinCre +/Cre (n = 12) mice, which begin to express CRE in the mesoderm at E7 and the endothelium at E8.5, respectively 26, 39 ( Fig. 3a) . We also examined cohorts of ROSA26 +/Confetti Vav1 +/Cre (n = 10) mice, which express CRE in newly specified haematopoietic stem and progenitor cells (HSPCs) beginning at E11.5 (Figs 3a and 4a,b) 40 . Confetti-allele recombination efficiency ranged from 45% to 80% amongst these mouse strains (Supplementary Fig. 2c and Table 1 Fig. 3a,b) . By inputting the resulting average log 10 (CV) of RFP, YFP and CFP in the PB of each of these mouse cohorts into our formula for estimating cell numbers and adjusting for recombination efficiency, we calculated that approximately 719 (95% CI [713, 726] . We did not observe any dramatic differences in the number of precursors contributing to distinct blood lineages in these strains (Fig. 3f) .
To validate these estimates using an unbiased system, ROSA26 +/Confetti ubiquitin +/ERT2-Cre mice were subjected to a single dose of TAM at E7.5 (n = 5) or E8.5 (n = 6) (Fig. 3d) . Here, CRE expression is ubiquitous and can be activated via TAM treatment 41 . The average log 10 (CV) of RFP, YFP and CFP in the PB of cohorts of ROSA26 +/Confetti ubiquitin +/ERT2-Cre mice exposed to TAM at E7.5 and E8.5 yielded, respectively, estimates of 617 (95% CI[324, 1,174]) and 538 (95% CI[273, 1,057]) initiating events (Table 1  and Supplementary Table 1 ). These data confirm that hundreds of precursors present between E7.5-E8.5 and E8.5-E9.5 contribute to lifelong haematopoiesis.
Vav1-Cre drives CRE expression throughout FL haematopoietic ontogeny when FL HSPCs are thought to expand rapidly [42] [43] [44] . Given that Vav1-Cre labelling of haematopoietic cells begins at E11.5, we expected Vav1-Cre to capture this expansion and were therefore surprised that Vav1-Cre yielded similar initiating cell number estimates to Flk1-Cre and VE-cadherin-Cre (Table 1 and  Supplementary Table 1) . One technical explanation for this result is that Vav1-Cre-driven labelling might saturate prior to the expansion of FL HSPCs. However, Vav1-Cre labelled 80% of adult PB but only about 33% of E13.5 and E14.5 CD45 + c-Kit + FL cells, suggesting that Vav1-Cre labelling has not yet saturated the haematopoietic system at these developmental time points (Supplementary Fig. 2c and Fig. 4a,b) . Further, we observed minimal delay in the onset of detectable Confetti fluorescence in 4-OHT-treated iCCs and recombination of the Confetti allele (Fig. 4c) . However, we did note a slight delay between administration of 4-OHT and detectable DNA recombination ( Fig. 4c(top) and Supplementary Fig. 7 ). Thus, altogether these data suggest the presence of a previously unappreciated developmental bottleneck in the FL, or temporally downstream of Vav1-Cre-dependent label saturation, that restricts the number of cells that ultimately establish the final pool of HSPCs that sustain lifelong haematopoiesis. In sum, our data show that 600-700 precursors emerging first from the mesoderm and then from the endothelium before transiting through the FL ultimately establish the pool of HSPCs that sustain lifelong haematopoiesis.
Haemogenic endothelium is specified between E8.5 and E10.5
We next sought to define the temporal window when HE precursors are specified. Here, we employed ROSA26 +/Confetti Cdh5 +/ERT2-Cre mice, in which CRE activity is activated in the endothelium by TAM 45 . The temporal window post-delivery of TAM during which CRE is active has not been rigorously defined. WBM on the same day as TAM treatment ( Fig. 5b(i) ), despite high CD45.2 + PB engraftment in all recipients (>90%, Fig. 5b (ii)). Recipients were treated with TAM 12 weeks post-transplant, resulting in 10-40% Confetti + PB, confirming robust engraftment of ROSA26 ERT2-Cre/Confetti WBM ( Fig. 5b(iii) ,(iv)). These data suggest that the effective window of TAM-mediated Confetti-allele recombination following a single treatment with TAM is <24 h. Dams pregnant with ROSA26 +/Confetti Cdh5 +/ERT2-Cre embryos were treated with a single dose of TAM at E7.5, E8.5, E9.5, E10.5 or E11.5 (Fig. 5c) . Remarkably, 10-24 weeks after birth, Confetti + cells were mostly observed in the PB of mice treated with TAM at E8.5 (≈7% Confetti + PB) and E9.5 (≈8% Confetti + PB) (Figs 5d and 3f ), with minimal labelling at E7.5. Labelling abruptly disappeared in the PB of mice treated with TAM at E10.5 and E11.5 ( Fig. 5d) , even though yolk sac and AGM endothelium were clearly labelled (Fig. 5e) . Since the window of TAM activity is <24 h, our data suggest that all HE throughout the embryo that contribute to lifelong haematopoiesis are established by E10. 25 (Fig. 5f ). We and others have shown that nascent HSC specification occurs during AGM-explant culture (Fig. 2e,f) 
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. Strikingly, Confetti labelling was undetectable in the CD45.2 + PB of 4/4 mice transplanted with AGM-explant cells (Fig. 5g) , confirming that recruitment of HE ceases before E10.5 and is not reactivated during AGM-explant culture. The sum of the average estimate of the frequency of haemogenic precursors contributing to lifelong haematopoiesis at E8.5 and E9.5 is ≈660 (Table 1  and Supplementary Table 1) . Although the same haemogenic precursor might be Confetti-labelled at both E8.5 and E9.5, this value matches our estimates of the number of haematopoietic precursors contributing to lifelong haematopoiesis gleaned from
Many c-Kit + intra-aortic clusters are polyclonal Finally, we investigated the clonality of intra-aortic haematopoietic clusters (IACs) by examining the dorsal aorta of E11.5 ROSA26 +/Confetti VE-cadherin +/Cre mice (Fig. 6a) . Here, among c-Kit + clusters harbouring at least one Confetti colour, 38/50 IACs of ≥3 cells per cluster were a mixture of unlabelled cells and cells expressing distinct Confetti colours (Fig. 6b and Supplementary  Figs 5 and 6a) . These data suggest a polyclonal origin for many IACs. composition. Each bar represents the absolute number of clusters of each size. Two-cell clusters, n = 56; three-cell clusters, n = 16; four-cell clusters, n = 28; five-cell clusters, n = 8; six-cell clusters, n = 10; seven-cell clusters, n = 3; eight-cell clusters, n = 5; more than eight-cell clusters, n = 4. Source data are provided in Supplementary Table 1. were isolated by flow cytometry from E10.5 ROSA26 +/Confetti VEcadherin +/Cre embryos, cultured for seven days, and then analysed for Confetti labelling ( Supplementary Fig. 6c,d ). Cultured Confetti − cells remained Confetti − (Supplementary Fig. 6d ). Expanded YFP + , CFP + and RFP + cultures were composed nearly entirely of cells expressing the original Confetti colour plated ( Supplementary  Fig. 6d ). These data suggest that colour identity is fixed by E10.5 and are consistent with the idea that polyclonal clusters do not result from ongoing CRE activity post-specification. However, to definitively rule out this possibility, we examined c-Kit + IACs in E11.5 ROSA26 +/Confetti Cdh5 +/ERT2-Cre embryos treated with TAM at E7.5 and E8.5. Here, we also observed clusters composed of a mixture of unlabelled and Confetti + cells, further supporting that many IACs are polyclonal (Fig. 6a) .
DISCUSSION
Recent studies have taken advantage of multicolour labelling to study unappreciated blood properties 13, 46 . In zebrafish, a brainbowbased Zebrabow system revealed that 30 HSC clones are present during peak production from aortic endothelium. Here, we analyse the clonal complexity of the emerging mammalian haematopoietic system using an approach that avoids transplantation, disruption or culture of the developing embryo. We observed that, within a defined range of initiating events (Fig. 1f) , a linear relationship exists between the SSV in the distribution of Confetti allele-driven colours and the number of initially labelled cells. Through this approach, we estimated that between 600 and 700 developmental precursors contribute to lifelong haematopoiesis. This is far greater than previous estimates of the frequency of HSC and HSPC precursors in the E10.5 and E11.5 AGM [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] 15 . However, our data are consistent with the large number of IACs observed in E10.5 embryos (609 ± 84 c-Kit + cells in the dorsal aorta and about 300 in the vitelline and umbilical arteries) 47 . Our findings also agree with the rapid expansion (that is, 200-fold) of nascent HSPCs during AGM-explant culture (Fig. 2f and Table 1) 37 . Importantly, AGMexplant culture probably underestimates this potential, as explant culture conditions are almost certainly sub-optimal relative to the in vivo specification niche. Further, transplantation-based methods of estimation yield a snapshot view of the frequency of functional HSCs at a given point in time, while our approach captures the cumulative formation of nascent HSPCs that emerge and then exit the AGM. Perhaps more importantly, our approach did not require an artificial ex vivo niche or nascent HSCs to repopulate adult recipients. Indeed, newly specified E9.5 yolk sac and E10.5 AGM HSPCs are more readily functionally detected when transplanted into neonatal rather than adult mice [48] [49] [50] [51] . These studies strongly suggest that many nascent HSPCs have not yet acquired the ability to robustly engraft the adult BM microenvironment.
We also report that the specification of HE from endothelium occurs between E8.5 and E10.5 of murine development, after which it abruptly quenches and cannot be reactivated. Recent reports in zebrafish suggest the presence of an active cellular niche promoting the specification of nascent HSCs from the HE 52 . Our data suggest that a similar niche may also exist during mammalian development. It would be interesting to explore whether the abrupt quenching of HE specification results from an active mechanism of suppression or the passive loss of critical signals that cease or become distal as the embryo develops and grows.
Our study exposed several unexpected layers of active regulation of haematopoietic development. Importantly, our data suggest the presence of a developmental bottleneck in or downstream of the FL that restricts the number of cells contributing to lifelong haematopoiesis. We speculate that this 'bottleneck' could represent finite niche space capable of supporting the expanding FL HSPC pool or early BM. Further, the polyclonal nature of many IACs suggests that the cells that form these clusters may be highly migratory (that is, IACs may result from the migration and coalescence of multiple nascent HSPC throughout the dorsal aorta or other sites of active haematopoietic specification). Interestingly, clusters composed of only two cells (and labelled with at least one Confetti colour) were nearly always monoclonal (25/27, Fig. 6b ), suggesting that many nascent HSPCs divide shortly after specification from HE before incorporating into larger IACs. Although it was recently demonstrated that some cluster-derived cells are functional HSCs in vivo, more work is required to determine whether each cell within a cluster contributes to lifelong haematopoiesis 53 . In sum, our data reveal unexpected layers of active regulation of haematopoietic development, including a developmental bottleneck in or downstream of the FL and an abrupt quenching in the recruitment of haemogenic endothelium. Remarkably, we reveal that lifelong mammalian haematopoiesis is founded by hundreds of mesodermal and endothelial precursors during embryogenesis.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper. tm1(cre/ERT2)Tyj /J) and ubiquitin +/ERT2-Cre (B6.Cg-Tg(UBC-cre/ERT2)1Ejb/1J) mice were acquired from The Jackson Laboratory and housed in a pathogen-free facility. Animals were treated and analysed at different time points starting at embryonic development day E7.5 up to 16 weeks during their adult life. Animals of both sexes were used without being specifically selected for sex. All animal experiments were carried out according to procedures approved by the St Jude Children's Research Hospital Institutional Animal Care and Use Committee and comply with all relevant ethical regulations regarding animal research.
Tamoxifen delivery in vivo. To activate CRE in utero, pregnant females were treated by oral gavage with 1 mg tamoxifen (TAM, T5648, Sigma-Aldrich) suspended in 95% sunflower seed oil (Sigma-Aldrich) and 5% ethanol (Pharmco-AAPER) for one or two days. To determine the in vivo window of TAM activity, C57BL/6J pregnant females (8-12 weeks old) or CD45.2 + /CD45.1 + C57BL/6J recipients of ROSA26 ERT2-Cre/Confetti whole bone marrow were treated by oral gavage with a single dose of 1 mg of TAM; CD45.2 + /CD45.1 + C57BL/6J recipients were re-treated 12 weeks post-transplant with TAM for five consecutive days with 1 mg of TAM by oral gavage. Eight-week-old ROSA26 ERT2-Cre/Confetti mice were also treated for five consecutive days with 1 mg of TAM by oral gavage. PB analysis. PB was collected from the retro-orbital plexus in heparinized capillary tubes (Fisherbrand) and lysed in red blood cell lysis buffer (Sigma-Aldrich). Cells were stained with the following antibodies: CD45.1-APC (A20) (Biolegend); B220-PECy7 and CD8-PECy7 (53-6.7) (Tonbo Biosciences); CD45.2-V500 (104), B220-PerCPCy5.5 (RA3-6B2), Gr1-PerCPCy5.5 (RB6-8C5), Cd11b-PerCPCy5.5 (M1/70) and CD4-PECy7 (RM4-5) (BD Biosciences). Unlysed blood was stained with CD41-PerCPe710 (eBioMWReg30) (eBioscience) and Ter119-PECy7 (TER-119) (Biolegend). All antibodies were used at 1:200 dilution. 4 ,6-diamidino-2-phenylindole (DAPI) staining was used to gate live events. Confetti-colour Fig. 1a ). After analysis of single-colour compensation controls was complete, compensation settings were affirmed via analysis of a sample expressing all Confetti colours (typically unstained PB from a ROSA26 +/Confetti VEcadherin +/Cre mouse). At least 10,000 cells were analysed per sample. Transduced HL60 were kindly provided by the Flow Laboratory Core Unit at St Jude Children's Research Hospital.
Tissues analysis. Hind limb skeletal muscle, kidney, lung, eye and skin were harvested from ROSA26 +/Confetti E2a +/Cre mice (four months old). Single-cell suspensions were generated either by mechanical disruption (kidney, lung and eye) or by mechanical/enzymatic dissociation (skeletal muscle, collagenase/dispase solution (2.5 U ml −1 , Sigma-Aldrich); skin, trypsin (TrypLE, Thermo Fisher Scientific)). Cells derived from lung and kidney were stained with CD45-APC (30-F11) (eBioscience) to exclude blood cells from the analysis. Confetti-labelling analysis was performed on a FACSAria III (BD Biosciences) and the data were analysed with FlowJo version 9.4.11 (Tree Star). All antibodies were used at 1:200 dilution.
Derivation and culture of inducible Confetti cells (iCCs). Mouse embryonic fibroblasts (MEFs) were isolated from E13.5 ROSA26
ERT2-Cre/Confetti embryos and propagated and immortalized according to standard protocols 26 . MEFs were cultured in Dulbecco's minimal essential medium (DMEM, Thermo Fisher Scientific) with 10% fetal calf serum (FCS, Omega Scientific). For CRE activation, MEFs were exposed to 600 nM (Z)-4-hydroxytamoxifen (4-OHT, H7904-Sigma). iCCs were negative for mycoplasma contamination, tested by the ATCC Universal Mycoplasma Detection Kit (Cat N0 30-1012k).
Derivation of formula from empirical data generated with iCCs and statistics. The coefficients of variance (CV, standard deviation/mean) for each colour at each cell number were calculated and log 10 -transformed. Next, the data were visualized against the log 10 -transformed cell number to determine the empirical relationship and range of linearity. Then, the data for all well-measured colours (that is, Confetti colours present >10%, Supplementary Fig. 1b) were used to derive a linear equation using regression defined by the determined range (50-2,500 cells). Before fitting this linear regression, normality was tested on the data using the Shapiro-Wilk test. For this formula, the goodness of fit was calculated using the coefficient of determination, the adjusted R 2 . Confidence intervals (CI; 95%) for this empirical formula were also calculated.
In vitro analysis of fidelity of Confetti-based estimates under conditions of variable reporter labelling efficiency and number of cells analysed. A total of 250 or 750 iCCs were cultured in 2-600 nM 4-OHT (nine replicates for each condition) and expanded. Cultures were then analysed by flow cytometry by acquiring 100-10,000 total live events. These data were then examined for the SSV in the Confetti colours.
Calculation of estimates of the number of initiating cells for mouse strains.
Estimates were calculated by inputting the average of the CVs obtained from each of the other three Confetti colours into the empirical formula. Estimates were normalized to CRE efficiency = (10 (−1.56×log 10 (CV)+1.47) )/(efficiency/100). CRE efficiency was calculated as the percentage of labelling of the total PB. The 95% confidence intervals were calculated in the same way as: (10 (−2.1×log 10 (CV)+1.06) )/(efficiency/100) − (10 (−1.02×(log 10 (CV)+1.89) )/(efficiency/100). GFP was excluded from all analyses, because GFP + PB cells always fell below the minimum threshold for precision.
Propidium iodide staining. Cells were harvested and fixed in cold 70% ethanol for 30 min at 4 • C, treated with RNase (DNase-free) (Calbiochem, Merck Millipore; 100 µg ml −1 ) and stained with propidium iodide (Calbiochem) at 0.2 µg ml −1 for 45 min at 4 • C.
Karyotype analysis. Cells were harvested by routine cytogenetic methods after a five hour colcemid treatment (0.2 µg ml −1 , Life Technologies). Slides were allowed DOI: 10.1038/ncb3607
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to air-dry for optimal banding of the chromosomes with Trypsin-EDTA 1× (Cellgro/Corning) and Wright's stain (Sigma-Aldrich).
AGM-explant culture. E11.5 AGM explants were cultured at the air/liquid interface on 0.65 µm DV Durapore Membrane Filters (Merck Millipore) in Iscove's modified Dulbecco's medium-Glutamax (IMDM-Glutamax, Thermo Fisher Scientific), 20% FCS (Omega Scientific), 0.1 mM 2-mercaptoethanol (Thermo Fisher Scientific), and 100 units ml −1 of penicillin/streptomycin (Thermo Fisher Scientific) supplemented with recombinant murine SCF, recombinant murine IL-3, and recombinant murine Flt3-ligand (Peprotech, all at 100 ng ml −1 ) for three days. Explants were then dissociated with collagenase (0.0012 g ml −1 , Sigma-Aldrich) in phosphatebuffered saline (PBS, Thermo Fisher Scientific) supplemented with 10% FCS (Omega Scientific).
Transplant of Cdh5 +/ERT2-Cre ROSA26 +/Confetti AGM explants exposed to tamoxifen at E10.5. ROSA26 +/Confetti Cdh5 +/ERT2-Cre embryos were treated in utero at E10.5 with a single dose of TAM (1 mg) by oral gavage. AGMs were collected from these embryos at E11.5 and cultured as explants for three days as indicated above. Explants were then dissociated and transplanted at one embryo equivalent per mouse into lethally irradiated CD45.1 + /CD45.2 + recipients along with 200,000 CD45.1 + C57BL/6.SJL WBM cells. Recipients were examined for Confetti labelling in PB beginning at four weeks post-transplant. +FBS 20% (Omega)). OP9 cells were washed with PBS and co-cultures were then maintained in IMDM-Glutamax medium (Thermo Fisher) supplemented with 100 ng ml −1 each of rmSCF, rmFLT3L, rmIL-3 and 20 ng ml −1 of rmTPO (Peprotech). All antibodies were used at 1:200 dilution.
Analysis of
Analysis of intra-aortic cell clusters. E11.5 AGMs were isolated and fixed in 4% paraformaldehyde (Electron Microscopy Sciences) for 1 h at 4 • C, washed three times with PBS (30 min per wash), blocked in 0.4% Triton X-100 (Biorad) with 3% donkey serum (Sigma) and 3% goat serum (16210-064, Invitrogen) in PBS at 4 • C for four hours and permeabilized. AGMs were then incubated with α-c-Kit (clone D13A2, Cell Signaling Technology) at 1:300 in 0.4% Triton X-100 and 1% skimmed milk in PBS overnight, washed three times with 0.4% Triton X-100 in PBS and then incubated with a goat anti-rabbit-Alexa-647 secondary antibody (1:2,500, clone A21245, Thermo Fisher Scientific) overnight in 0.4% Triton X-100 and 1% skimmed milk in PBS. AGMs were then embedded in 4.5% low-melting-point agarose (Thermo Fisher Scientific) and sectioned (200 µm slices) using a vibratome (microtome with vibrating blade VT1200, Leica Byosystems). AGMs were imaged using Nunc Lab-Tek II Chambered Coverglass (155382, Thermo Fisher Scientific) on a Zeiss LSM 780 Confocal Microscope (Zeiss) using a ×40, 1.1 NA water immersion lens. Spectral images were linearly unmixed using ZEN 2012 software (Zeiss). Statistics and reproducibility. Summary statistics, including mean and standard deviation, were reported for analyses. Each process was performed using STATA/MP 14.1 (Statacorp). All in vitro experiments were reliably reproduced at least three times with the exception of Fig. 1g ,h, which was reproduced twice and Fig. 2c , which has one replicate. Sample size and number of experiment replicates are detailed for each figure. Major findings, which include the generation of an empirical formula to predict the number of initiating events and the estimation that lifelong haematopoiesis is established by hundreds of precursors, were validated in different experimental settings. First, the empirical formula was verified in vivo in three independent transplant approaches using bone marrow from ROSA26 +/Confetti VE-cadherin +/Cre and ROSA26 +/Confetti Flk1 +/Cre donors and via transplantation of AGMs and AGM explants from E11.5 ROSA26 +/Confetti VE-cadherin +/Cre embryos. Second, the estimation that hundreds of precursors during murine ontogeny contribute to lifelong haematopoiesis was confirmed using different mouse strains, that is, ROSA26 +/Confetti VE-cadherin +/Cre , ROSA26 +/Confetti Flk1 +/Cre , ROSA26 +/Confetti Vav1 +/Cre , ROSA26 +/Confetti ubiquitin +/ERT2-Cre treated at different time points (E7.5 and E8.5) and Cdh5 +/ERT2-Cre ROSA26 +/Confetti treated at E8.5 and E9.5. All other data supporting the findings of this study are available from the corresponding author upon reasonable request. Fig. 5a and Supplemental Fig. 5 to illustrate non-specific GFP signal. Green arrow denotes true GFP+ cells while white arrow denotes non-specific GFP signal. b, qRT-PCR for CRE expression in Confetti+ and Confetti-VE-Cadherin+CD45-cells isolated from E8.5, E9.5, or E10.5 ROSA26 +/Confetti VE-Cadherin +/Cre and ROSA26 +/ Confetti VE-Cadherin +/+ embryos. Here, iCCs were used as a positive control for CRE expression. mRNA relative expression levels were normalized to CRE expression in iCCs. Each bar represents an independent biological replicate.
Analysis of onset recombination and fluorescence in
Each biological replicate was generated in an independent experiment where different embryonic tissues of the same time-point and genotype were analyzed together. mRNA extraction, cDNA generation and qRT-PCR were run at the same time for all samples. Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Experimental design
Sample size
Describe how sample size was determined.
No power estimation was done prior to study
Data exclusions
Describe any data exclusions. Empirical data was not employed in linear regression model when it was observed to depart from linearity after data collection and visualization during the model development phase of the study. Criteria were not pre-established. GFP data was also excluded as it was unresponsive in the test cell types (Table1, Figure 1h , Figure 2b , c, f; Figure 3c , 3e, 3f; Supplemental Fig. 2d ; Supplemental Tables1-4). Confetti cells double positive for different Confetti colors were excluded from the analysis (Supplemental Fig.1 ).
Replication
Describe whether the experimental findings were reliably reproduced.
Experiments were reliably reproduced. Major findings, which include the generation of an empirical formula to predict the number of initiating events and the estimation that life-long hematopoiesis is established by hundreds of precursors were validated in different experimental settings. First, empirical formula was verified in vivo in three independent transplant approaches using bone marrow from ROSA26+/Confetti VE-Cadherin+/Cre and ROSA26+/Confetti Flk1+/Cre donors and via transplantion of AGMs and AGM explants from E11.5 ROSA26+/Confetti VE-Cadherin+/Cre embryos. Second, the estimation that hundreds of precursors during murine ontogeny contribute to life-long hematopoiesis was confirmed using different mice strains, i.e. ROSA26+/Confetti VE-Cadherin+/Cre, ROSA26+/Confetti Flk1+/Cre, ROSA26+/Confetti Vav1+/Cre, ROSA26+/Confetti Ubiquitin+/ERT2-Cre treated at different time points (E7.5 and E8.5) and Cdh5+/ERT2-CreROSA26+/Confetti treated at E8.5 and E9.5.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
No randomization method was used. Animals were allocated into experimental groups according to genotype.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Although no specific methods were used for blinding, blood samples were collected from mice by one individual and then analyzed by flow cytometry by a different individual, at which time genotypes were not known. All statistics were performed by an independent biostatistics expert who was unaware of the biological significance of distinct groups of mice being examined.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
No private code was used for critical results, rather commercial statistical software (Stata/MP 14.1) was employed.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
inducible Confetti Cells (iCCs) are available upon request.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
